前收市價 | 125.81 |
開市 | 126.18 |
買盤 | 127.36 x 500 |
賣出價 | 127.45 x 500 |
今日波幅 | 125.78 - 128.65 |
52 週波幅 | 74.75 - 142.00 |
成交量 | |
平均成交量 | 3,223,459 |
市值 | 50.661B |
Beta 值 (5 年,每月) | 1.21 |
市盈率 (最近 12 個月) | 82.72 |
每股盈利 (最近 12 個月) | 1.54 |
業績公佈日 | 2024年7月25日 - 2024年7月29日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 153.14 |
Dexcom stock shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Ecolab's (ECL) robust performance across the majority of its segments drives its first-quarter sales despite business challenges.